The Patent Finder

New Gadolinium Chelate Compounds for Use in Magnetic Resonance Imaging

Bayer Pharma Aktiengesellschaft

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 4 of these applications claim priority to application PCT/EP2016/062105, filed May 30, 2016. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 10,137,209New Gadolinium Chelate Compounds for Use in Magnetic Resonance Imaging
In force
 · High confidence
Bayer Pharma AktiengesellschaftIn force
High confidence
US 10,722,601Gadolinium Chelate Compounds for Use in Magnetic Resonance Imaging
In force
 · High confidence
Bayer Pharma AktiengesellschaftIn force
High confidence
US 11,491,245Gadolinium Chelate Compounds for Use in Magnetic Resonance Imaging
In force
 · High confidence
Bayer Pharma AktiengesellschaftIn force
High confidence
US 12,478,696Gadolinium Chelate Compounds for Use in Magnetic Resonance Imaging
In force
 · High confidence
Bayer Pharma AktiengesellschaftIn force
High confidence
Application 17/979,367New Gadolinium Chelate Compounds for Use in Magnetic Resonance Imaging
Pending
Not granted
Bayer Pharma AktiengesellschaftPendingNot granted
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Bayer Pharma Aktiengesellschaft.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited